Skip to main content
. 2023 Nov 28;11(2):2302037. doi: 10.1002/advs.202302037

Figure 7.

Figure 7

A diagram of EBF2 interacting with KMT2D‐mediated H3K4me1 to suppress pancreatic cancer progression.